CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome

CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome

The C-X-C motif chemokine ligand 17 (CXCL17) is chemotactic for myeloid cells, exhibits bactericidal activity, and exerts anti-viral functions. This chemokine is constitutively expressed in the respiratory tract, suggesting a role in lung defenses. However, little is known about the participation of...

Full description

Bibliographic Details
Main Authors: Jose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, Citlaltepetl Salinas-Lara, Carlos Sánchez-Garibay, Cesar Luna-Rivero, Erika Mariana Hernández-Montiel, Luis Alejandro Fernández-López, María Fernanda Cabrera-Cornejo, Eduardo Misael Choreño-Parra, Alfredo Cruz-Lagunas, Andrea Domínguez, Eduardo Márquez-García, Carlos Cabello-Gutiérrez, Francina Valezka Bolaños-Morales, Lourdes Mena-Hernández, Diego Delgado-Zaldivar, Daniel Rebolledo-García, Parménides Guadarrama-Ortiz, Nora E. Regino-Zamarripa, Criselda Mendoza-Milla, Ethel A. García-Latorre, Tatiana Sofía Rodríguez-Reyna, Diana Cervántes-Rosete, Carmen M. Hernández-Cárdenas, Shabaana A. Khader, Albert Zlotnik, Joaquín Zúñiga
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
influenza A(H1N1)
SARS-CoV-2
COVID-19
tuberculosis
chemokines
CXCL17
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.633297/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.633297/full

Similar Items